<p>全球市場正在應對複雜的局面，近期的地緣政治緊張局勢和能源市場波動影響了投資者情緒。在這種背景下，便宜股成為尋求低價增長潛力的投資者的有趣機會。儘管 “便宜股” 這個術語可能顯得過時，但這些較小或較新的公司在強大的財務支持和明確的增長前景下可以提供可觀的價值。</p>
<h3>全球十大便宜股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>北東橡膠 (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>亞洲醫學與農業實驗室及研究中心 (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>前瞻集團控股 (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>揚子江造船 (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>綜合診斷控股 (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們全球便宜股篩選器中的 3469 只股票的完整列表。</p>
<p>我們將查看篩選工具中的一些最佳選擇。</p>
<h2>中珠醫療控股有限公司 (SHSE:600568)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 中珠醫療控股有限公司專注於中國藥物的研究、開發、生產和銷售，市值為人民幣 54.8 億元。</p>
<p><strong>運營：</strong> 該公司在中國的運營收入為人民幣 5.7062 億元。</p>
<p><strong>市值：</strong> 人民幣 54.8 億</p>
<p>中珠醫療控股有限公司市值為人民幣 54.8 億元，收入為人民幣 5.7062 億元，且無債務，現金流足以支撐超過三年的運營，儘管尚未盈利。公司的管理層和董事會相對較新，平均任期為 1.3 年，表明可能會有戰略轉變。最近的進展包括由共青城美華騰龍啓飛投資合夥企業收購 10.38% 的股份，交易金額約為人民幣 4 億元，儘管面臨持續的盈利挑戰和-32.97% 的負股本回報率，但仍顯示出投資者的興趣。</p>
<ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解中珠醫療控股有限公司的複雜性。</li>
<li>查看中珠醫療控股有限公司的歷史業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 財務狀況分析截至 2026 年 4 月</p>
<h2>南方泵業 (SZSE:300145)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 南方泵業有限公司從事泵產品的研究、設計、開發、生產和銷售，市值為人民幣 86.3 億元。</p>
<p><strong>運營：</strong> 南方泵業有限公司未報告具體的收入細分。</p>
<p><strong>市值：</strong> 人民幣 86.3 億</p>
<p>南方泵業有限公司市值為人民幣 86.3 億元，在過去五年中表現出持續的盈利增長，年均增長 67.1%，儘管最近的增長放緩至 5.9%。儘管最新財務結果受到 1.083 億元的一次性損失影響，但公司仍保持財務穩定，短期資產為 55 億元，超過短期和長期負債。其淨債務與股本比率為 37.4%，利息覆蓋率良好，得益於充足的盈利表現。公司的市盈率為 34.5 倍，低於中國市場平均水平。</p>
<ul>
<li>點擊這裏查看完整的分析健康報告，以更深入瞭解南方泵業。</li>
<li>通過查看我們的增長報告，瞭解南方泵業的盈利前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis"/></p>
<p>SZSE:300145 財務狀況分析截至 2026 年 4 月</p>
<h2>物通控股集團 (SZSE:300292)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 物通控股集團有限公司在中國製造和銷售智能通信設備，市值為人民幣 64.9 億元。</p>
<p><strong>運營：</strong> 該公司未報告任何具體的收入細分。</p>
<p><strong>市值：</strong> 人民幣 64.9 億</p>
<p>物通控股集團市值為人民幣 64.9 億元，過去一年表現出 121.8% 的顯著盈利增長，超過了通信行業。公司的債務與股本比率在五年內顯著改善，從 44.2% 降至 16.8%，且現金超過總債務，表明財務健康良好。其市盈率為 62.8 倍，低於行業平均水平，儘管其股本回報率較低，僅為 8.1%。短期資產足以覆蓋負債，利息支付也得到了 EBIT（24 倍）的良好覆蓋。</p>
<ul>
<li>在我們的財務健康報告中更深入地瞭解物通控股集團的潛力。</li>
<li>查看我們的歷史業績報告，以獲取物通控股集團的業績記錄。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis"/></p>
<p>SZSE:300292 財務狀況分析截至 2026 年 4 月</p>
<h2>關鍵要點</h2>
<ul>
<li>解鎖更多寶藏！我們的全球便宜股票篩選器為您挖掘了 3466 家更多公司供您探索。點擊這裏揭開我們精心策劃的 3469 家全球便宜股票名單。</li>
<li>對其他選擇感興趣？通過穩健的分紅支付者來多樣化您的投資組合，以提供可靠的收入來源，以應對潛在的市場動盪。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<h3>估值是複雜的，但我們在這裏為您簡化。</h3>
<p>通過我們的詳細分析，發現南方泵業是否被低估或高估，分析內容包括 <strong>公允價值估計、潛在風險、分紅、內部交易及其財務狀況。</strong></p>
<p>獲取免費分析</p>

ST中珠

<p>中珠醫療控股有限公司是一家市值為 54.8 億人民幣的低價股，專注於中國的藥物開發。儘管尚未盈利，但公司擁有足夠的現金流，並且最近通過收購 10.38% 的股份吸引了投資者的關注。該公司實現了 5.7062 億人民幣的收入，但股本回報率為-32.97%。文章還強調了其他低價股，包括南方泵業和五通控股集團，展示了它們在市場波動中財務健康和增長潛力</p>

<p>Global markets have been navigating a complex landscape, with recent geopolitical tensions and energy market volatility influencing investor sentiment. Against this backdrop, penny stocks emerge as intriguing opportunities for investors seeking growth potential at lower price points. Although the term &#34;penny stocks&#34; may seem outdated, these smaller or newer companies can offer substantial value when supported by strong financials and clear growth prospects.</p>
<div class="lb-trans"><p>全球市場正在應對複雜的局面，近期的地緣政治緊張局勢和能源市場波動影響了投資者情緒。在這種背景下，便宜股成為尋求低價增長潛力的投資者的有趣機會。儘管 “便宜股” 這個術語可能顯得過時，但這些較小或較新的公司在強大的財務支持和明確的增長前景下可以提供可觀的價值。</p>
</div><h3>Top 10 Penny Stocks Globally</h3>
<div class="lb-trans"><h3>全球十大便宜股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>North East Rubber (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Foresight Group Holdings (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Integrated Diagnostics Holdings (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>北東橡膠 (SET:NER)</td>
<td>THB4.88</td>
<td>THB9.02B</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>亞洲醫學與農業實驗室及研究中心 (SET:AMARC)</td>
<td>THB3.40</td>
<td>THB1.42B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>前瞻集團控股 (LSE:FSG)</td>
<td>£3.745</td>
<td>£425.41M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Angler Gaming (DB:0QM)</td>
<td>€0.31</td>
<td>€239.95M</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>PC Partner Group (SGX:PCT)</td>
<td>SGD1.58</td>
<td>SGD612.86M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>CNMC Goldmine Holdings (Catalist:5TP)</td>
<td>SGD1.53</td>
<td>SGD620.09M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Focus Point Holdings Berhad (KLSE:FOCUSP)</td>
<td>MYR0.485</td>
<td>MYR298.25M</td>
<td>✅ 5 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>揚子江造船 (SGX:BS6)</td>
<td>SGD3.99</td>
<td>SGD15.7B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>綜合診斷控股 (LSE:IDHC)</td>
<td>$0.61</td>
<td>$354.61M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 3,469 stocks from our Global Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們全球便宜股篩選器中的 3469 只股票的完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我們將查看篩選工具中的一些最佳選擇。</p>
</div><h2>Zhongzhu Healthcare HoldingLtd (SHSE:600568)</h2>
<div class="lb-trans"><h2>中珠醫療控股有限公司 (SHSE:600568)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Zhongzhu Healthcare Holding Co., Ltd focuses on the research, development, production, and sale of drugs in China with a market capitalization of CN¥5.48 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 中珠醫療控股有限公司專注於中國藥物的研究、開發、生產和銷售，市值為人民幣 54.8 億元。</p>
</div><p><strong>Operations:</strong> The company generates CN¥570.62 million in revenue from its operations within China.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司在中國的運營收入為人民幣 5.7062 億元。</p>
</div><p><strong>Market Cap:</strong> CN¥5.48B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民幣 54.8 億</p>
</div><p>Zhongzhu Healthcare Holding Co., Ltd, with a market cap of CN¥5.48 billion and revenue of CN¥570.62 million, is debt-free and has a sufficient cash runway exceeding three years despite being unprofitable. The company's management and board are relatively new, with an average tenure of 1.3 years, indicating potential for strategic shifts. Recent developments include the acquisition of a 10.38% stake by Gongqingcheng Meihua Tenglong Qifei Investment Partnership Enterprise for approximately CN¥400 million, signaling investor interest despite ongoing profitability challenges and negative return on equity at -32.97%.</p>
<div class="lb-trans"><p>中珠醫療控股有限公司市值為人民幣 54.8 億元，收入為人民幣 5.7062 億元，且無債務，現金流足以支撐超過三年的運營，儘管尚未盈利。公司的管理層和董事會相對較新，平均任期為 1.3 年，表明可能會有戰略轉變。最近的進展包括由共青城美華騰龍啓飛投資合夥企業收購 10.38% 的股份，交易金額約為人民幣 4 億元，儘管面臨持續的盈利挑戰和-32.97% 的負股本回報率，但仍顯示出投資者的興趣。</p>
</div><ul>
<li>Navigate through the intricacies of Zhongzhu Healthcare HoldingLtd with our comprehensive balance sheet health report here.</li>
<li>Examine Zhongzhu Healthcare HoldingLtd's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解中珠醫療控股有限公司的複雜性。</li>
<li>查看中珠醫療控股有限公司的歷史業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SHSE:600568 財務狀況分析截至 2026 年 4 月</p>
</div><h2>Nanfang Pump Industry (SZSE:300145)</h2>
<div class="lb-trans"><h2>南方泵業 (SZSE:300145)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Nanfang Pump Industry Co., Ltd. is involved in the research, design, development, production, and sale of pump products both in China and internationally, with a market cap of CN¥8.63 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 南方泵業有限公司從事泵產品的研究、設計、開發、生產和銷售，市值為人民幣 86.3 億元。</p>
</div><p><strong>Operations:</strong> No specific revenue segments are reported for Nanfang Pump Industry Co., Ltd.</p>
<div class="lb-trans"><p><strong>運營：</strong> 南方泵業有限公司未報告具體的收入細分。</p>
</div><p><strong>Market Cap:</strong> CN¥8.63B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民幣 86.3 億</p>
</div><p>Nanfang Pump Industry Co., Ltd., with a market cap of CN¥8.63 billion, has demonstrated consistent earnings growth over the past five years, averaging 67.1% annually, although recent growth slowed to 5.9%. Despite a large one-off loss of CN¥108.3 million affecting its latest financial results, the company remains financially stable with short-term assets of CN¥5.5 billion exceeding both short and long-term liabilities. Its net debt to equity ratio is satisfactory at 37.4%, and interest coverage is not an issue due to adequate earnings performance. The company's Price-to-Earnings ratio stands at 34.5x, below the Chinese market average.</p>
<div class="lb-trans"><p>南方泵業有限公司市值為人民幣 86.3 億元，在過去五年中表現出持續的盈利增長，年均增長 67.1%，儘管最近的增長放緩至 5.9%。儘管最新財務結果受到 1.083 億元的一次性損失影響，但公司仍保持財務穩定，短期資產為 55 億元，超過短期和長期負債。其淨債務與股本比率為 37.4%，利息覆蓋率良好，得益於充足的盈利表現。公司的市盈率為 34.5 倍，低於中國市場平均水平。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Nanfang Pump Industry.</li>
<li>Understand Nanfang Pump Industry's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏查看完整的分析健康報告，以更深入瞭解南方泵業。</li>
<li>通過查看我們的增長報告，瞭解南方泵業的盈利前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/c1415cd4-7614-4b7e-9fe7-b95f444bf490/chart/financial-position-analysis"/></p>
<p>SZSE:300145 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SZSE:300145 財務狀況分析截至 2026 年 4 月</p>
</div><h2>Wutong Holding Group (SZSE:300292)</h2>
<div class="lb-trans"><h2>物通控股集團 (SZSE:300292)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Wutong Holding Group Co., Ltd. manufactures and sells intelligent telecommunication devices in China and has a market cap of CN¥6.49 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 物通控股集團有限公司在中國製造和銷售智能通信設備，市值為人民幣 64.9 億元。</p>
</div><p><strong>Operations:</strong> The company has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司未報告任何具體的收入細分。</p>
</div><p><strong>Market Cap:</strong> CN¥6.49B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民幣 64.9 億</p>
</div><p>Wutong Holding Group, with a market cap of CN¥6.49 billion, has shown impressive earnings growth of 121.8% over the past year, outpacing the Communications industry. The company's debt to equity ratio has significantly improved from 44.2% to 16.8% in five years, and it holds more cash than total debt, indicating strong financial health. Its Price-to-Earnings ratio of 62.8x is below the industry average, suggesting potential value for investors despite its low Return on Equity at 8.1%. Short-term assets comfortably cover liabilities, and interest payments are well covered by EBIT (24x).</p>
<div class="lb-trans"><p>物通控股集團市值為人民幣 64.9 億元，過去一年表現出 121.8% 的顯著盈利增長，超過了通信行業。公司的債務與股本比率在五年內顯著改善，從 44.2% 降至 16.8%，且現金超過總債務，表明財務健康良好。其市盈率為 62.8 倍，低於行業平均水平，儘管其股本回報率較低，僅為 8.1%。短期資產足以覆蓋負債，利息支付也得到了 EBIT（24 倍）的良好覆蓋。</p>
</div><ul>
<li>Take a closer look at Wutong Holding Group's potential here in our financial health report.</li>
<li>Review our historical performance report to gain insights into Wutong Holding Group's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的財務健康報告中更深入地瞭解物通控股集團的潛力。</li>
<li>查看我們的歷史業績報告，以獲取物通控股集團的業績記錄。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/60afb4ed-6349-4e73-8644-08bda46406fb/chart/financial-position-analysis"/></p>
<p>SZSE:300292 Financial Position Analysis as at Apr 2026</p>
<div class="lb-trans"><p>SZSE:300292 財務狀況分析截至 2026 年 4 月</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><ul>
<li>Unlock more gems! Our Global Penny Stocks screener has unearthed 3,466 more companies for you to explore.Click here to unveil our expertly curated list of 3,469 Global Penny Stocks.</li>
<li>Curious About Other Options? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖更多寶藏！我們的全球便宜股票篩選器為您挖掘了 3466 家更多公司供您探索。點擊這裏揭開我們精心策劃的 3469 家全球便宜股票名單。</li>
<li>對其他選擇感興趣？通過穩健的分紅支付者來多樣化您的投資組合，以提供可靠的收入來源，以應對潛在的市場動盪。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><h3>Valuation is complex, but we're here to simplify it.</h3>
<div class="lb-trans"><h3>估值是複雜的，但我們在這裏為您簡化。</h3>
</div><p>Discover if Nanfang Pump Industry might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p>
<div class="lb-trans"><p>通過我們的詳細分析，發現南方泵業是否被低估或高估，分析內容包括 <strong>公允價值估計、潛在風險、分紅、內部交易及其財務狀況。</strong></p>
</div><p>Access Free Analysis</p>
<div class="lb-trans"><p>獲取免費分析</p>
</div>

探索全球便士股：中珠醫療控股有限公司領銜我們的三人組